M08.461 Pauciarticular juvenile rheumatoid arthritis, right knee

Name of the Condition

• Pauciarticular Juvenile Rheumatoid Arthritis, Right Knee

Summary

Pauciarticular juvenile rheumatoid arthritis is a subtype of juvenile idiopathic arthritis characterized by inflammation in four or fewer joints during the first six months of disease onset. The "right knee" designation specifies the right knee joint as the site of involvement. This condition primarily affects children and may involve large joints such as the knees, ankles, or wrists. Systemic symptoms are less common compared to other subtypes, but eye inflammation (uveitis) can occur, particularly in patients with a positive antinuclear antibody (ANA) test.

Causes

The exact cause is unknown, but it is believed to be an autoimmune disorder where the immune system mistakenly attacks healthy joint tissues. Genetic factors and environmental triggers may contribute to disease development, though specific triggers are not well-defined.

Risk Factors

• Age (most commonly diagnosed in children under 16).
• Female gender (higher prevalence, especially in those with ANA positivity).
• Positive antinuclear antibody (ANA) test, which increases risk of uveitis.
• Family history of autoimmune diseases.

Symptoms

• Joint pain, swelling, and stiffness in the right knee, often worse in the morning.
• Reduced range of motion in the affected knee.
• Possible eye inflammation (uveitis), which may be asymptomatic initially.
• Limping or difficulty bearing weight on the right leg.

Diagnosis

Diagnosis involves a combination of clinical evaluation, medical history, and diagnostic tests. Physical examination assesses joint involvement, while blood tests (e.g., inflammatory markers, ANA) and imaging (e.g., X-rays, ultrasound) may be used to confirm inflammation and rule out other conditions. Documentation of joint involvement within six months of onset is critical for classification.

Treatment Options

Treatment focuses on reducing inflammation, preserving joint function, and managing symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain and swelling. Intra-articular corticosteroid injections may be administered directly into the right knee for localized relief. Physical therapy helps maintain mobility and strength. In some cases, disease-modifying antirheumatic drugs (DMARDs) or biologics are prescribed to slow disease progression.

Prognosis and Follow-Up

Prognosis varies, with many children achieving remission. However, some may develop persistent joint damage or uveitis. Regular follow-up with a pediatric rheumatologist is essential to monitor disease activity, adjust treatment, and screen for complications. Early intervention improves long-term outcomes.

Complications

• Chronic joint damage or deformity in the right knee.
• Uveitis (eye inflammation), which can lead to vision loss if untreated.
• Growth disturbances in the affected limb.
• Functional limitations affecting mobility.

Lifestyle & Prevention

• Maintain a balanced diet to support overall health.
• Engage in low-impact exercises (e.g., swimming) to preserve joint function.
• Protect the right knee from excessive strain during activities.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new joints become involved, or eye pain, redness, or vision changes occur. Prompt evaluation is necessary to prevent complications like uveitis or joint damage.

Tips for Medical Coders

Document the specific joint involvement (right knee) and confirm the pauciarticular subtype criteria (four or fewer joints affected within six months of onset). Ensure clinical notes support the diagnosis and site specificity. Code M08.461 is used when the right knee is the documented site of pauciarticular juvenile rheumatoid arthritis.